Rheumatoid Arthritis Research Today is a free monthly online journal that collates and summarizes the latest research about Rheumatoid Arthritis, including details on treatment, symptoms, causes, medication.

Volume 4 (2007), Issue 4 (April)

1. Validation of the comprehensive international classification of functioning, disability and health core set for rheumatoid arthritis: the perspective of physical therapists.
   Phys Ther, 87(4): 368-84. [Abstract] [Full-text]
2. Stereoselective disposition of fenoprofen in plasma and synovial fluid of patients with rheumatoid arthritis.
   Chirality, 19(4): 255-63. [Abstract] [Full-text]
3. A modified Hohmann method for hallux valgus and telescoping osteotomy for lesser toe deformities in patients with rheumatoid arthritis.
   Clin Rheumatol, 26(5): 748-52. [Abstract] [Full-text]
4. Depressive symptoms in early rheumatoid arthritis: a comparative longitudinal study.
   Clin Rheumatol, 26(5): 753-8. [Abstract] [Full-text]
5. Household work disability of Arab housewives with rheumatoid arthritis.
   Clin Rheumatol, 26(5): 759-63. [Abstract] [Full-text]
6. The significance of platelet activation in rheumatoid arthritis.
   Clin Rheumatol, 26(5): 768-71. [Abstract] [Full-text]
7. Anti-beta2-glycoprotein I in Sjogren's syndrome is associated with parkinsonism.
   Clin Rheumatol, 26(5): 743-7. [Abstract] [Full-text]
8. Plasma homocysteine status in patients with ankylosing spondylitis.
   Clin Rheumatol, 26(5): 739-42. [Abstract] [Full-text]
9. Influence of intraarticular corticosteroid administration on serum cytokines in rheumatoid arthritis.
   Clin Rheumatol, 26(5): 845-8. [Abstract] [Full-text]
10. Occurrence of sacroiliitis in patients with seronegative oligoarthritis.
    Clin Rheumatol, 26(5): 715-7. [Abstract] [Full-text]
11. High prevalence of metabolic syndrome in patients with ankylosing spondylitis.
    Clin Rheumatol, 26(5): 710-4. [Abstract] [Full-text]
12. The evaluation of quality of life in fibromyalgia syndrome: a comparison with rheumatoid arthritis by using SF-36 Health Survey.
    Clin Rheumatol, 26(5): 679-84. [Abstract] [Full-text]
13. The changes in monosaccharide composition of immunoglobulin G in the course of rheumatoid arthritis.
    Clin Rheumatol, 26(5): 685-90. [Abstract] [Full-text]
14. Hemophagocytic syndrome in one patient with adult-onset Still's disease. Presentation with febrile neutropenia.
    Clin Rheumatol, 26(5): 797-800. [Abstract] [Full-text]
15. Remission of rheumatoid arthritis after acute disseminated varicella-zoster infection.
    Clin Rheumatol, 26(5): 779-80. [Abstract] [Full-text]
16. Urticaria and angiedema-like skin reactions in a patient treated with adalimumab.
    Clin Rheumatol, 26(5): 787-8. [Abstract] [Full-text]
17. The efficacy and tolerability of newer biologics in rheumatoid arthritis: best current evidence.
    Curr Opin Rheumatol, 19(3): 308-13. [Abstract] [Full-text]
18. Update on cytokines in rheumatoid arthritis.
    Curr Opin Rheumatol, 19(3): 296-301. [Abstract] [Full-text]
19. Macrophages and their products in rheumatoid arthritis.
    Curr Opin Rheumatol, 19(3): 289-95. [Abstract] [Full-text]
20. The role of T cells in rheumatoid arthritis: new subsets and new targets.
    Curr Opin Rheumatol, 19(3): 284-8. [Abstract] [Full-text]
21. Early rheumatoid arthritis.
    Curr Opin Rheumatol, 19(3): 278-83. [Abstract] [Full-text]
22. New therapeutic approaches for spondyloarthritis.
    Curr Opin Rheumatol, 19(3): 259-64. [Abstract] [Full-text]
23. Emerging cytokine targets in rheumatoid arthritis.
    Curr Opin Rheumatol, 19(3): 246-51. [Abstract] [Full-text]
24. Cyclosporine and tacrolimus for the treatment of rheumatoid arthritis.
    Curr Opin Rheumatol, 19(3): 238-45. [Abstract] [Full-text]
25. Glucocorticoids: action and new therapeutic insights in rheumatoid arthritis.
    Curr Opin Rheumatol, 19(3): 233-7. [Abstract] [Full-text]
26. Anti-inflammatory and lysosomal stability actions of Cleome gynandra L. studied in adjuvant induced arthritic rats.
    Food Chem Toxicol, 45(6): 1001-12. [Abstract] [Full-text]
27. Distribution of HLA-B27 subtypes in ankylosing spondylitis in an Israeli population.
    Arch Med Res, 38(4): 452-5. [Abstract] [Full-text]
28. Treatment with total alkaloids from Radix Linderae reduces inflammation and joint destruction in type II collagen-induced model for rheumatoid arthritis.
    J Ethnopharmacol, 111(2): 322-8. [Abstract] [Full-text]
29. Upper-airway obstruction after short posterior occipitocervical fusion in a flexed position.
    Spine, 32(8): E267-70. [Abstract] [Full-text]
30. Adalimumab for the treatment of ankylosing spondylitis.
    Expert Opin Pharmacother, 8(6): 831-8. [Abstract] [Full-text]
31. Notes on the kidney and its diseases for the neurologist.
    J Neurol Neurosurg Psychiatry, 78(5): 444-9. [Abstract] [Full-text]
32. Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis.
    Am J Hum Genet, 80(5): 867-75. [Abstract] [Full-text]
33. ICOS and B7 costimulatory molecule expression identifies activated cellular subsets in rheumatoid arthritis.
    Cytometry A, 71(5): 317-26. [Abstract] [Full-text]
34. Gene expression profiling of rheumatoid arthritis synovial cells treated with antirheumatic drugs.
    J Biomol Screen, 12(3): 328-40. [Abstract] [Full-text]
35. Successful treatment of a patient with refractory adult Still's disease by tacrolimus.
    Mod Rheumatol, 17(2): 167-70. [Abstract] [Full-text]
36. Inositol 1,4,5-trisphosphate receptors are autoantibody target antigens in patients with Sjögren's syndrome and other systemic rheumatic diseases.
    Mod Rheumatol, 17(2): 137-43. [Abstract] [Full-text]
37. Replacement of the first metatarsophalangeal joint with a Swanson implant accompanied by open-wedge osteotomy of the first metatarsal bone for hallux valgus in rheumatoid arthritis.
    Mod Rheumatol, 17(2): 110-4. [Abstract] [Full-text]
38. Long-term results of open elbow synovectomy for rheumatoid arthritis.
    Mod Rheumatol, 17(2): 106-9. [Abstract] [Full-text]
39. Influence of methotrexate dose on its efficacy and safety in rheumatoid arthritis patients: evidence based on the variety of prescribing approaches among practicing Japanese rheumatologists in a single institute-based large observational cohort (IORRA).
    Mod Rheumatol, 17(2): 98-105. [Abstract] [Full-text]
40. A relationship between pharmacokinetics (PK) and the efficacy of infliximab for patients with rheumatoid arthritis: characterization of infliximab-resistant cases and PK-based modified therapy.
    Mod Rheumatol, 17(2): 83-91. [Abstract] [Full-text]
41. HLA-DRB1*04 gene polymorphisms and expressions profiles of interleukin-18 and interleukin-18 binding protein following in vitro stimulation in human peripheral blood mononuclear cells of healthy individuals and patients with rheumatoid arthritis.
    Life Sci, 80(20): 1887-96. [Abstract] [Full-text]
42. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome.
    Clin Exp Immunol, 148(2): 281-7. [Abstract] [Full-text]
43. Expression of large tenascin-C splice variants in synovial fluid of patients with rheumatoid arthritis.
    J Orthop Res, 25(5): 563-8. [Abstract] [Full-text]
44. Progressive and concordant expression of PKC-eta and iNOS phenotypes in monocytes from patients with rheumatoid arthritis: association with disease severity.
    J Histochem Cytochem, 55(5): 495-503. [Abstract] [Full-text]
45. Kinetic modeling of contrast-enhanced MRI: an automated technique for assessing inflammation in the rheumatoid arthritis wrist.
    Ann Biomed Eng, 35(5): 781-95. [Abstract] [Full-text]
46. Daily health status registration (patient diary) in patients with rheumatoid arthritis: a comparison between personal digital assistant and paper-pencil format.
    Arthritis Rheum, 57(3): 454-60. [Abstract] [Full-text]
47. Therapy of patients with rheumatoid arthritis: outcome of infliximab failures switched to etanercept.
    Arthritis Rheum, 57(3): 448-53. [Abstract] [Full-text]
48. Evaluation of the preliminary definitions of minimal disease activity and remission in an early seropositive rheumatoid arthritis cohort.
    Arthritis Rheum, 57(3): 440-7. [Abstract] [Full-text]
49. Measuring fatigue in rheumatoid arthritis: a systematic review of scales in use.
    Arthritis Rheum, 57(3): 429-39. [Abstract] [Full-text]
50. Experiences of mothers living with inflammatory arthritis.
    Arthritis Rheum, 57(3): 381-8. [Abstract] [Full-text]
51. Work disability among two cohorts of women with recent-onset rheumatoid arthritis: a survival analysis.
    Arthritis Rheum, 57(3): 372-80. [Abstract] [Full-text]
52. A shot in the dark: failing to recognize the link between physical and mental illness.
    J Gen Intern Med, 22(5): 677-80. [Abstract] [Full-text]
53. The influence of MHC class II molecules containing the rheumatoid arthritis shared epitope on the immune response to aggrecan G1 and its peptides.
    Scand J Immunol, 65(5): 444-52. [Abstract] [Full-text]
54. A possible role for TSLP in inflammatory arthritis.
    Biochem Biophys Res Commun, 357(1): 99-104. [Abstract] [Full-text]
55. Ankylosing spondylitis.
    Lancet, 369(9570): 1379-90. [Abstract] [Full-text]
56. Cell surface CCR5 density determines the intensity of T cell migration towards rheumatoid arthritis synoviocytes.
    Clin Immunol, 123(2): 148-54. [Abstract] [Full-text]
57. Concurrent gene therapy strategies effectively destroy synoviocytes of patients with rheumatoid arthritis.
    Rheumatology (Oxford), 46(5): 783-9. [Abstract] [Full-text]
58. Effects of exercise on aerobic capacity and fatigue in women with primary Sjogren's syndrome.
    Rheumatology (Oxford), 46(5): 868-71. [Abstract] [Full-text]
59. What's in season for rheumatoid arthritis patients? Seasonal fluctuations in disease activity.
    Rheumatology (Oxford), 46(5): 846-8. [Abstract] [Full-text]
60. The overall status in rheumatoid arthritis (OSRA) measure--further evidence to support its use in clinical practice.
    Rheumatology (Oxford), 46(5): 849-55. [Abstract] [Full-text]
61. Combined analysis of three whole genome linkage scans for Ankylosing Spondylitis.
    Rheumatology (Oxford), 46(5): 763-71. [Abstract] [Full-text]
62. Pulmonary rheumatoid nodules demonstrating features usually associated with rheumatoid synovial membrane.
    Rheumatology (Oxford), 46(5): 811-4. [Abstract] [Full-text]
63. Down-regulation of leucocyte immunoglobulin-like receptor expression in the synovium of rheumatoid arthritis patients after treatment with disease-modifying anti-rheumatic drugs.
    Rheumatology (Oxford), 46(5): 742-51. [Abstract] [Full-text]
64. Methyl glyoxal elevation is associated with oxidative stress in rheumatoid arthritis.
    Free Radic Res, 41(5): 507-14. [Abstract] [Full-text]
65. Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss.
    Am J Ophthalmol, 143(5): 840-846. [Abstract] [Full-text]
66. Predictors of functional disability in rheumatoid arthritis: results from a 13-year prospective study.
    Disabil Rehabil, 29(10): 805-15. [Abstract] [Full-text]
67. Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome.
    Cornea, 26(4): 431-7. [Abstract] [Full-text]
68. siRNA targeting PLK-1 induces apoptosis of synoviocytes in rheumatoid arthritis.
    Biochem Biophys Res Commun, 357(2): 353-9. [Abstract] [Full-text]
69. Identification of disease-associated proteins by proteomic approach in ankylosing spondylitis.
    Biochem Biophys Res Commun, 357(2): 531-6. [Abstract] [Full-text]
70. The cornea in Sjogren's syndrome: an in vivo confocal study.
    Invest Ophthalmol Vis Sci, 48(5): 2017-22. [Abstract] [Full-text]
71. Adult Still's disease associated with cytomegalovirus infection.
    J Infect Chemother, 13(2): 114-7. [Abstract] [Full-text]
72. Quantitative structure-activity relationship of peptides binding to the class II major histocompatibility complex molecule Aq associated with autoimmune arthritis.
    J Med Chem, 50(9): 2049-59. [Abstract] [Full-text]
73. Osteoarthritis: a comorbid marker for longer life?
    Ann Epidemiol, 17(5): 380-4. [Abstract] [Full-text]
74. Expression of angiopoietin-1 in osteoblasts and its inhibition by tumor necrosis factor-alpha and interferon-gamma.
    Transl Res, 149(5): 265-73. [Abstract] [Full-text]
75. Ankylosing spondylitis is linked to Klebsiella--the evidence.
    Clin Rheumatol, 26(6): 858-64. [Abstract] [Full-text]
76. Persistence of interleukin 7 activity and levels on tumour necrosis factor alpha blockade in patients with rheumatoid arthritis.
    Ann Rheum Dis, 66(5): 664-9. [Abstract] [Full-text]
77. Investigation of genetic variation across the protein tyrosine phosphatase gene in patients with rheumatoid arthritis in the UK.
    Ann Rheum Dis, 66(5): 683-6. [Abstract] [Full-text]
78. Clinical trial of a leucotriene B4 receptor antagonist, BIIL 284, in patients with rheumatoid arthritis.
    Ann Rheum Dis, 66(5): 628-32. [Abstract] [Full-text]
79. Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study.
    Ann Rheum Dis, 66(5): 589-98. [Abstract] [Full-text]
80. Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis.
    Ann Rheum Dis, 66(5): 670-5. [Abstract] [Full-text]
81. Reporting of radiographic methods in randomised controlled trials assessing structural outcomes in rheumatoid arthritis.
    Ann Rheum Dis, 66(5): 651-7. [Abstract] [Full-text]
82. Arthritis of the large joints - in particular, the knee - at first presentation is predictive for a high level of radiological destruction of the small joints in rheumatoid arthritis.
    Ann Rheum Dis, 66(5): 646-50. [Abstract] [Full-text]
83. Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort.
    Ann Rheum Dis, 66(5): 633-8. [Abstract] [Full-text]
84. Is shared care with annual hospital review better value for money than predominantly hospital-based care in patients with established stable rheumatoid arthritis?
    Ann Rheum Dis, 66(5): 658-63. [Abstract] [Full-text]
85. A randomised, double-blind, placebo-controlled trial of a recombinant version of human alpha-fetoprotein (MM-093) in patients with active rheumatoid arthritis.
    Ann Rheum Dis, 66(5): 687-9. [Abstract] [Full-text]
86. Poor relationship between joint swelling detected on physical examination and effusion diagnosed by ultrasonography in glenohumeral joints in patients with rheumatoid arthritis.
    Clin Rheumatol, 26(6): 865-7. [Abstract] [Full-text]
87. Is three selected parameters adequate to monitor rheumatoid arthritis?
    Clin Rheumatol, 26(6): 911-4. [Abstract] [Full-text]
88. Association of acute anterior uveitis with disease activity, functional ability and physical mobility in patients with ankylosing spondylitis: a cross-sectional study of Chinese patients in Taiwan.
    Clin Rheumatol, 26(6): 953-7. [Abstract] [Full-text]
89. Response to one infusion predicts subsequent improvement as well as the rate of relapse of ankylosing spondylitis infused with three pulses of infliximab.
    Clin Rheumatol, 26(6): 920-6. [Abstract] [Full-text]
90. NOD2 allele variants in patients with rheumatoid arthritis.
    Clin Rheumatol, 26(6): 868-71. [Abstract] [Full-text]
91. Anxiety and depression in patients with rheumatoid arthritis.
    Clin Rheumatol, 26(6): 872-8. [Abstract] [Full-text]
92. Rapid improvement in rheumatoid arthritis patients on combination of methotrexate and infliximab: clinical and magnetic resonance imaging evaluation.
    Clin Rheumatol, 26(6): 941-6. [Abstract] [Full-text]
93. Long-term anti-TNFalpha therapy for ankylosing spondylitis in two patients with chronic HBV infection.
    Clin Rheumatol, 26(6): 950-2. [Abstract] [Full-text]
94. A still image of a transient rash captured by a mobile phone.
    Clin Rheumatol, 26(6): 979-80. [Abstract] [Full-text]
95. Leukocytapheresis for the treatment of refractory systemic-onset juvenile idiopathic arthritis.
    Clin Rheumatol, 26(6): 1014-6. [Abstract] [Full-text]
96. A case report of tumor necrosis factor-alpha antibody-induced thrombocytopenia associated with emerging IgM anticardiolipin antibody in patients with scleroderma overlap/rheumatoid arthritis.
    Clin Rheumatol, 26(6): 988-90. [Abstract] [Full-text]

© 2004-2008 Rheumatoid Arthritis Research Today. All Rights Reserved.